. Geldanamycin prevents hemorrhage-induced ATP loss by overexpressing inducible HSP70 and activating pyruvate dehydrogenase.
heat shock protein 70; intestine HEMORRHAGE is often associated with systemic inflammatory response syndrome (SIRS), multiple organ dysfunction (MOD), and multiple organ failure (MOF) (3, 12) , and the documented loss of ATP is believed to play a central role in tissue pathology. Interference with the synthesis of ATP in mitochondria results in cell apoptosis, and, therefore, inhibition of ATP loss may prevent hemorrhage-associated clinical manifestations (1, 12) . The addition of ATP-MgCl 2 (23) and ethyl pyruvate (7) in resuscitation fluids has been shown to maintain tissue ATP levels and limit tissue injury. Geldanamycin (GA), an inducible heat shock protein 70 kDa (HSP70i) and an inducible nitric oxide synthase (iNOS) inhibitor, can block the expression of iNOS and its transcriptional enhancer Kruppellike factor (KLF)6 in organs of mice subjected to hemorrhage. GA-induced HSP70i formed complexes with iNOS and KLF6 (13, 14) .
The mechanisms that underlie the ATP loss observed in organs of animals after significant hemorrhage are not clear. It is known that Ca 2ϩ and Na ϩ break the high-energy bond of the ATP molecule, whereas K ϩ and Mg 2ϩ help rebuild it (26) . It is possible, therefore, that increases in intracellular Ca 2ϩ concentration induced by hypoxia under hemorrhagic shock conditions lead to hydrolysis of ATP molecules. The alternative possibility is that the expression of pyruvate dehydrogenase (PDH) and its enzymatic activity are altered by hemorrhage, an aspect that has not been studied before. PDH is the enzyme that converts pyruvate to acetyl CoA, which enters the tricarbonic acid cycle, through which significant amounts of ATP are generated (29) . Any reduction of PDH protein and/or its enzymatic activity could result in a reduction of ATP. On the other hand, increased PDH protein or its enzymatic activity could increase ATP levels.
We hypothesized that treatment with GA could block the hemorrhage-induced ATP loss by altering the expression of HSP70i and the expression and activity of PDH that lead to prevention of organ injury. In this study, we found that hemorrhage reduced ATP in various mouse organs and reduced PDH protein and enzymatic activity. GA treatment prevented the hemorrhage-induced ATP loss and organ injury probably by inducing the expression of HSP70i and PDH and by activating PDH.
METHODS
This research was conducted in compliance with the Animal Welfare Act and other Federal statutes and regulations relating to animals and experiments involving animals and adheres to the principles stated in the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
Experimental protocol. Experiments were conducted using the mouse model described by Song et al. (28) . Male Swiss Webster mice weighing 25-35 g were briefly anesthetized with isoflurane, and 40% of the calculated blood volume was removed over a 1-min period by cardiac puncture with a 26-gauge needle. Mean arterial blood pressure fell from 80 to 40 mmHg in the 2 h after treatment. Treated mice were allowed to respond for 1, 3, 6, 12, 24, and 48 h. Sham-treated animals underwent cardiac puncture, but no blood was removed. In different experiments, mice were pretreated with 10% DMSO-saline or GA (1 g/g body wt) in 10% DMSO-saline by an intraperitoneal injection 16 h before hemorrhage (25) . These mice were then subjected to 40% hemorrhage and allowed to respond for 6 h before they were killed. A small portion of the lung, jejunum, kidney, heart, brain, and liver was removed from the treated mice and frozen immediately at Ϫ70°C until it was used for immunoblotting and biochemical assays. Another set of tissues was used for histology examination.
Tissues were minced, sonicated for 15 s, and then centrifuged at 10,000 g for 10 min. The supernatant was saved so that the the total amount of protein in each lysate sample could be determined and immunoblot analysis performed. The cellular ATP and PDH levels were measured. Proteins and moieties were assessed by immunoprecipitation and immunoblotting between HSP70i and PDH.
Histopathological assessment. Small intestinal tissue specimens were rinsed in cold saline solution and immediately fixed in 10% buffered formalin phosphate. The tissue was then embedded in paraffin, sectioned transversely, and stained with hematoxylin-eosin. The mucosal crypt depth and width and villus height were measured. Mucosal damage for each slide was graded on the six-tiered scale defined by Chiu et al. (3a) , as follows: grade 0, normal mucosa; grade 1, development of subepithelial spaces near the tips of the villi with capillary congestion; grade 2, extension of the subepithelial space with moderate epithelial lifting from the lamina propria; grade 3, significant epithelial lifting along the length of the villi with a few denuded villus tips; grade 4, denuded villi with exposed lamina propria and dilated capillaries; and grade 5, disintegration of the lamina propria, hemorrhage, and ulceration.
Cell culture. Human intestinal epithelial T84 cells, FHs74 Int cells, and CRL-1550 cells (American Type Cell Culture; Rockville, MD) were grown in DMEM, hybrid-care medium, and RPMI 1640, respectively, in a humidified incubator with a 5% CO 2 atmosphere. Each medium was supplemented with 2 mM glutamine, 4.5 g/l glucose, 10% FBS, 100 U/ml penicillin, and 100 g/ml streptomycin; pH 7.4 (Quality Biological; Gaithersburg, MD). Cells were fed every 3-4 days.
HSP70 short interfering RNA transfection. To decrease HSP70 protein, RNA interference technology was used. Two designed pairs of oligoduplexes targeted against HSP70 (GenBank Accession No. NM_005346) were purchased from Qiagen (Valencia, CA). The target sequences of those oligoduplexes are 5Ј-AAG GGU GUU UCG UUC CCU UUA-3Ј and 5Ј-AAC CGA UAU GUU CAU UAG AAU-3Ј, respectively. A nonspecific oligoduplex (nonsilencing control, targeting on 5Ј-AAU UCU CCG AAC GUG UCA CGU-3Ј) at the same final concentrations as the HSP70 RNA duplexes was used as a negative control. To maximize the short interfering (si)RNA silencing potential, siRNAs were heated for 1 min at 90°C followed by 60 min at 37°C before the siRNA transfection. Interested cells were grown in fresh medium without antibiotics for 24 h before the transfection. These cells were then transferred to each well in six-well plates (density: 2 ϫ 10 6 cells/well). The transient transfections with 50, 100, and 200 nM of each siRNA duplex were performed using Lipofectamine reagent (Invitrogen; Carlsbad, CA) according to the manufacturer's protocol. Cells were harvested and assayed 24 h after transfection.
HSP70 and iNOS gene contstructs. Two genes encoding HSP70 and iNOS were used in this study. The HSP70 gene (a gift from Dr. Richard I. Morimoto) was first cloned in 1985 (10) . The full length of the HSP70 gene contains 2,400 bp, and this gene was inserted with the enzymes BamH1 and EcoRI in the pH 2.3 plasmid. cDNA of human iNOS was obtained from Dr. N. Tony Eissa (Baylor College of Fig. 1 . Time course of ATP levels in lysates of organs of mice subjected to hemorrhage. Mice were exposed to hemorrhage and allowed to respond for 1, 3, 6, 12, 24, or 48 h (n ϭ 6). ATP levels in lysates of the jejunum (A), lung (B), heart (C), kidney (D), brain (E), and liver (F) were measured. Data collected from hemorrhaged organs were normalized to those from sham-operated organs (%Sham).
Medicine, Houton, TX) and was first published in 2001 (8) . A 3,362-bp coding sequence with HindIII and XhoI restriction sites at each terminal of the human iNOS gene was subcloned from this full length of human iNOS cDNA. Using PCR application, the forward and reverse primers were 5Ј-CT AAG CTT GTC ATG GCC TGT CCT TGG AAA TTT CTG TTC-3Ј and 5Ј-GAC TCG AGC TCA GAG CGC TGA CAT CTC CAG GCT-3Ј, respectively. After digestion and purification of the PCR amplification product, the expression cDNA sequence was used for insertion into the vector. The vector used in this study was pcDNA3 (Invitrogen). The HSP70 gene was cut with the enzymes BamHI and EcoRI and inserted into the pcDNA3 vector with T4 DNA ligase (5) . The expression cDNA of the iNOS gene was inserted between the HindIII and XhoI sites of the pcDNA 3.1 vector. The expression construct was then sequenced to confirm its correct sequence and open reading frame.
Transient gene transfection. Cultured cells (1.5 ϫ 10 6 ) were grown in six-well plates. Cells in each well were treated with 4 g iNOS or HSP70 expression plasmid in 0.5 ml of antibiotics-free growth medium using the Lipofectamine 2000 Transfection Kit (Invitrogene). An equal amount of cells was also mixed with blank pcDNA 3.1 vector as the control group. Then, 1.5 ml of DMEM were added to each well, and cells were placed back to the incubator for 24 h to allow the transient transfection.
Immunoprecipitation. Tissue lysates containing 300 g protein were incubated with the specified antibody (5 l), chilled on ice for 1 h, mixed with protein A/G agarose beads (50 l, Santa Cruz Biotechnology; Santa Cruz, CA), and incubated overnight on a nutator at 4°C. The immunoprecipitate was collected by centrifugation at 12,500 g for 10 min and washed twice with 500 l of stop buffer and once with 500 l PBS wash buffer. The pellet was resuspended in 50 l of electrophoresis sample buffer without 2-mercaptoethanol, boiled for 5 min, and then centrifuged for 30 s to remove the agarose beads. The supernatant was incubated with 5% 2-mercaptoethanol at 37°C for 1 h. Twenty-five microliters of sample were loaded onto precast 10% Tris-glycine polyacrylamide gels for Western blots.
Western blot analysis. Samples were resolved on SDS-polyacrylamide slab gels (precast 10% gel, Invitrogen). Protein was blotted onto a nitrocellulose membrane (type NC, 0.45 m, Schleicher and Schuell) using a Novex blotting apparatus and the manufacturer's protocol. The nitrocellulose membrane was blocked by incubation for 90 min at room temperature in PBS containing 5% nonfat dried milk. The blot was then incubated for 60 min at room temperature with the selected antibody against actin (Santa Cruz Biotechnology); HSP90, HSP60, and HSP40 (Santa Cruz Biotechnology); HSP70i (Amersham); or PDH (BD Transduction Laboratories; San Diego, CA) at 1 g/ml in PBS-5% BSA. The blot was washed three times (10 min each) in Tris-buffered saline-0.1% Tween 20 before it was incubated for 60 min at room temperature with a 1,000ϫ dilution of speciesspecific IgG peroxidase conjugate (Santa Cruz Biotechnology) in PBS-1% gelatin. The blot was washed six times (5 min each) in Tris-buffered saline-0.1% Tween 20 before detection of the peroxi- Fig. 2 . Geldanamycin (GA) inhibits the hemorrhage (HE)-induced decrease in ATP levels in mouse organs. Mice were treated with GA (1 g/g body wt) in 10% DMSO-saline by an intraperitoneal injection 16 h before hemorrhage (n ϭ 3-5). ATP levels in lysates of the jejunum (A), lung (B), heart (C), kidney (D), brain (E), and liver (F) were measured. *P Ͻ 0.05 vs. sham, GA, and GA ϩ HE; **P Ͻ 0.05 vs. sham, HE, and GA (determined by 2 -test).
dase activity using the Enhanced Chemiluminenscence Kit (Amersham Life Science Products).
Immunofluorescent staining for confocal microscopy. Cells (1 ϫ 10 5 ) were plated on a glass coverslip precoated with poly-L-lysine. After attachment, cells were fixed with 3.7% formaldehyde and permeabilized with 0.1% Triton X-100 in PBS for 10 min. Permeabilized cells were blocked with 2% BSA for 30 min and incubated with a mouse antihuman PDH monoclonal antibody (1:200 dilution, Molecular Probes) or a rabbit anti-human HSP70 polyclonal antibody (Upstate) at a dilution of 1:200 in PBS containing 2% BSA for 1 h. Cells were then incubated for 1 h with Alexa Fluor 488 goat anti-mouse IgG (1:400, Molecular Probes) and Alexa Fluor 594 goat anti-rabbit IgG (1:400 dilution, Molecular Probes). Between each step, three washes with PBS were applied. After being stained with antibodies, cells were mounted using a SlowFade Light Antifade Kit with 4Ј,6-diamidino-2-phenylindole (Molecular Probes) on a glass slide and inspected microscopically under a laser confocal scanning.
Measurements of cellular ATP level. Cellular ATP levels were determined using the ATP Bioluminescence Assay Kit HS II (Roche; Mannheim, Germany). Luminescence was measured with a TD-20/20 luminometer (Turner Designs; Sunnyvale, CA). Data were normalized to total protein, and the cellular ATP level is expressed as femtomoles per microgram of protein.
Measurements of PDH activity. The cell lysate in the assay buffer containing 1 mM DTT and PMSF was incubated with 0.2 mM Na ϩ -CoA for 15 min at 37°C. The mixture was then mixed with 1.25 mM oxaloacetate and 1.25 g 5,5-dithiobia(2-nitrobenzoic acid) and incubated for 10 min at 37°C. The final mixture was mixed with 5 units citrate synthase and read immediately at 412 nm at 30°C. The activity was normalized with the total protein concentration, and the specific activity is presented as microunits per microgram of protein.
Measurement of cell viability. Cell viability was determined by the trypan blue exclusion assay. Twenty microliters of cell suspension were mixed with 20 l of 0.4% trypan blue solution (Sigma Chemical; St. Louis, MO). The viability was calculated accordingly (16) .
Solutions. Na ϩ -Hanks' solution contained (in mM) 145 NaCl, 4. , 2 thiamine pyrophosphate, 1 MgCl2, 1 DTT, and 1 PMSF (pH 7.40 at 24°C). Stop buffer contained 50 mM Tris⅐HCl, 1% Nonidet P-40, 0.25% Na ϩ deoxycholate, 150 mM NaCl, 1 mM EDTA, 1 mM PMSF, 1 mM Na3VO4, 1 mM NaF, and 1 g/ml of aprotinin, leupeptin, and pepstatin.
Statistical analysis. All data are expressed as means Ϯ SE. Oneway ANOVA, two-way ANOVA, Studentized-range test, Bonferroni's inequality, and 2 -test were used for comparison of groups with 5% as the significance level.
Chemicals. GA was obtained from Sigma.
RESULTS
Hemorrhage decreases ATP levels in mouse organs. Hemorrhage results in decreased ATP levels in lung, ileum, and liver tissues (2, 3, 3a, 11-14, 24) , but the time course of the decrease has not been studied. Figure 1 demonstrates how hemorrhage affects the ATP level in a mouse hemorrhage model over time. In the mouse jejunum, ATP levels decreased within the first hour, returned to baseline at 12 h, but decreased again thereafter (Fig.  1A) . In lung (Fig. 1B) and heart (Fig. 1C) tissues, ATP levels decreased steadily within the first 12 h and remained low afterward. In contrast, ATP levels in the brain (Fig. 1E) decreased and reached the lowest point within 8 h and then returned to the baseline level at 24 h. In the kidney (Fig. 1D) , ATP levels decreased within 1 h, returned to baseline by the sixth hour, and remained at the baseline to 48 h. Unlike the jejunum, lung, heart, brain, and kidney, ATP levels in the liver (Fig. 1F) increased after hemorrhage and reached maximal levels at 24 h. Fig. 3 . GA limits the hemorrhage (HEMO)-induced pyruvate dehydrogenase (PDH) activity decrease. A: mice were subjected to hemorrhage and allowed to respond for 1, 3, 6, 12, 24, or 48 h (n ϭ 6). PDH activities in lysates of the hemorrhaged jejunum (HEMO) were measured. Data collected from the hemorrhaged jejunum were normalized to those from the sham-operated jejunum. *P Ͻ 0.05 vs. time 0 (determined by one-way ANOVA and Bonferroni's inequality). B: mice were pretreated with GA (1 g/g body wt) in 10% DMSO-saline by an intraperitoneal injection 16 h before hemorrhage (n ϭ 3-5). PDH activities in lysates of the hemorrhaged jejunum were measured. *P Ͻ 0.05 vs. sham, GA, and GA ϩ HEMO (determined by 2 -test). C: representative Western blots of PDH. D: the protein bands of PDH were quantitated densitometrically and normalized to that of actin. *P Ͻ 0.05 vs. sham, GA, and GA ϩ HEMO (determined by 2 -test).
Treatment with GA inhibits hemorrhage-induced ATP loss in mouse organs. We treated mice with GA 16 h before subjecting them to hemorrhage to determine whether it affected ATP levels in various tissues. Figure 2 shows that treatment with GA significantly limited ATP loss in jejunum ( Fig. 2A ) and brain (Fig. 2E ) tissues and fully blocked ATP loss in lung (Fig.  2B), heart (Fig. 2C), and kidney (Fig. 2D) tissues. GA treatment further increased ATP levels in the liver (Fig. 2F) .
Hemorrhage reduces PDH activity in the jejunum. Because it has been reported that increases in ATP levels mediated by PDH improved heart function and metabolism after hemorrhagic shock (18), we sought to determine whether the PDH activity changed in the organs of mice subjected to hemorrhage. Figure 3A demonstrates that hemorrhage causes a significant decrease in PDH activity in the jejunum at 6 h. PDH activity returned to the baseline level at 24 h.
GA inhibits the hemorrhage-induced decrease in PDH activity and protein expression in the jejunum. Because GA treatment was shown above to prevent the hemorrhage-induced ATP loss, we considered it likely that GA also prevented the hemorrhage-induced decrease in the PDH activity. Although GA treatment alone did not alter PDH activity, it prevented the hemorrhage-induced decrease in PDH activity in jejunum tissue lysates (Fig. 3B) . Immunoblot experiments showed that hemorrhage decreased the PDH protein level, and GA treatment prevented the decrease (Fig. 3, C and D) , suggesting that the decreased PDH activity is as a result of the decreased PDH protein level and that GA prevents the decrease. GA increases survival from hemorrhagic shock and prevents hemorrhage-induced organ injury. Six hours after hemorrhage, mice displayed 60% survival. In the presence of GA, 84% of hemorrhaged mice survived. Histological assessment of mouse Mice were pretreated with GA (1 g/g body wt) in 10% DMSO-saline by an intraperitoneal injection 16 h before hemorrhage (n ϭ 3-5). A: representative Western blot (top) of jejunum HSP70i complex formation with PDH. Lysates of mouse jejunum were immunoprecipitated (IP) with anti-HSP70i antibody, and PDH was then detected with anti-PDH antibody using immunoblot (IB) analysis. B: representative Western blot (top) of jejunum PDH complex formation with HSP70i. Lysates of mouse jejunum were immunoprecipitated with anti-PDH antibody, and HSP70i was then detected with antiHSP70i antibody using immunoblot analysis. *P Ͻ 0.05 vs. sham, GA, and GA ϩ HEMO; **P Ͻ 0.05 vs. sham, HEMO, and GA; ***P Ͻ 0.05 vs. sham, HEMO, GA ϩ HEMO (determined by 2 -test) . No IP, normal mouse serum with no antibody added for immunoprecipitation. jejunum tissue showed that hemorrhage reduced the villus height (Fig. 4, B and E) and increased the villus width (Fig. 4 , B and F) without altering the crypt depth (Fig. 4, B and G) , suggesting the presence of edema. The mucosal damage grade on the hemorrhaged jejunum was 3.6 Ϯ 0.3 (P Ͻ 0.05 vs. sham; Fig. 4H ).
GA treatment alone did not alter the villus height (Fig. 4 , C and E), villus width (Fig. 4, C and F) , or crypt depth (Fig. 4,  C and G) . However, GA treatment before hemorrhage protected the jejunum (Fig. 4, D-G) , and the mucosal damage grade was reduced to the level recorded in control animals (Fig. 4H) .
GA upregulates HSP70i in the jejunum and in cultured cells. Using immunoblot analysis, HSP90, HsP70i, and HSP60, but not HSP40, were detected in the sham-treated mouse jejunum. Hemorrhage did not alter these HSPs. GA treatment increased HSP70i expression but not that of HSP90 and HSP60 (Fig. 5,  A and C) . Similar findings were obtained with T84 cells and FHs75 Int cells (Fig. 5, B and D) .
HSP70 forms complexes with PDH in the jejunum. When jejunum tissue lysates were immunoprecipitated with anti-HSP70 antibody and the precipitates were immunoblotted with anti-PDH antibody, the PDH band was detected (Fig. 6A ), but bands of HSP90, HSP60, and HSP40 were not found (data not shown). When lysates were immunoprecipitated with anti-PDH antibody and the precipitates were then blotted with anti-HSP70 antibody, the HSP70 band was detected (Fig. 6B) . The intensity of each band indicated that GA treatment increased PDH and HSP70 proteins (Fig. 6) . No HSP90, HSP60, or HSP40 bands were detected (data not shown). Therefore, our data indicate that HSP70 can form a complex with PDH. (12) (13) (14) . To distinguish which of the two functions of GA contributed to its inhibitory actions on cellular ATP and PDH reduction caused by hemorrhage, we studied cultured intestinal epithelial T84 cells transiently transfected with either iNOS or HSP70 expression vectors (Fig. 7, A and B) to determine the effect of forced expression of these genes on ATP levels (Fig. 7D) , PDH expression (Fig. 7C) , and PDH enzymatic activity (Fig. 7E) . The HSP70 gene-transfected cells displayed a significantly higher ATP basal level than the control, vector-transfected, and iNOS gene-transfected cells (Fig. 7D) . Similarly, PDH protein and its enzymatic activity in HSP70 gene-transfected cells were significantly greater than in vector-transfected cells (Fig.  7, C and E) . Similar effects were found with cultured small intestinal cells (Fig. 8A) .
HSP70 overexpression increases ATP and PDH in cultured cells. GA is a HSP70i inducer and an iNOS inhibitor
To further confirm that the level of HSP70 present in cells can influence the levels of PDH and ATP, HSP70 RNA interference technology was used. Cells were treated with 50, 100, or 200 nM siRNA for 24 h. siRNA at 50 and 100 nM failed to inhibit ATP (data not shown), whereas at 200 nM, it significantly decreased HSP70 protein, PDH protein and activity, and the cellular ATP level (Fig. 8B) . These experiments strongly suggest that overexpression of HSP70 rather than iNOS accounts for increases in ATP levels.
HSP70 and PDH form complexes in cultured cells. We next wanted to confirm the observed association between HSP70 representative Western blot (top) of PDH complex formation with HSP70i. Lysates of T84 cells were immunoprecipitated with anti-PDH antibody, and HSP70i was then detected with anti-HSP70i antibody using immunoblot analysis. *P Ͻ 0.05 vs. control, gene transfection, and GA; **P Ͻ 0.05 vs. control, vector, and GA; ***P Ͻ 0.05 vs. control, vector, and gene transfection (determined by one-way ANOVA).
and PDH in jejunum tissues of GA-treated animals. To this end, we induced the expression of HSP70 in T84 intestinal epithelial cells either by transfecting a HSP70 expression vector or by treating them with GA. When T84 cell lysates were immunoprecipiated with anti-HSP70 antibody and the precipitates were blotted with anti-PDH antibody, the PDH band was detected (Fig. 9A) . When the lysates were immunoprecipitated with anti-PDH antibody and the precipitates were then blotted with anti-HSP70 antibody, the HSP70 band was detected (Fig. 9B) . The amounts of PDH (Fig. 9A, lane 4 vs.  lane 3) and HSP70 (Fig. 9B, lane 4 vs. lane 3) presented in the complexes also displayed that HSP70 overexpression resulted in increased PDH protein (Fig. 7) . These experiments further confirm that HSP70 associates with PDH.
GA increases ATP and PDH in cultured cells. Because the median inhibitory concentration of GA to block hypoxiainduced ATP loss in T84 cells is 0.76 Ϯ 0.24 M with the correlation coefficient being 0.9163 (J. G. Kiang, unpublished data), cells were treated with GA at 1 M for 16 h before the detection of HSP70 and PDH. GA treatment induced increases in PDH (Fig. 9A , lane 5 vs. lane 2) and HSP70 (Fig. 9B , lane 5 vs. lane 2), suggesting that GA increases PDH in addition to HSP70i.
The GA-induced increases in PDH protein (Fig. 10 , A vs. B) and HSP70i protein (Fig. 10, C vs. D) were further demonstrated with immunofluorescent staining using confocal microscopy. The data clearly showed a colocalization of PDH and HSP70i (Fig. 10, G and H (29) and because GA decreases intracellular Ca 2ϩ concentration (J. G. Kiang, unpublished data), we considered it possible that the GA effect on ATP levels was dependent on ionic compositions in the incubating buffer. Figure 11 shows the effects of various ionic compositions on the ATP level in the absence or presence of GA. When T84 cells were incubated in Na ϩ -Hanks' solution or ionic-modified buffers, we found that the removal of external Na ϩ decreased the ATP basal level, whereas in the presence of 25 mM K ϩ (normal is 4.5 mM), the ATP level increased remarkably. Removal of either external Ca 2ϩ or external Mg 2ϩ did not alter the ATP level. Treatment of cells with GA at 1 M significantly increased ATP levels in cells bathed in Na ϩ -containing, Ca 2ϩ -free, or Mg 2ϩ -free Hanks' solution. GA failed to increase ATP levels in Na ϩ -free buffer and did not further increase ATP levels in 25 mM 
DISCUSSION
MOF is known to occur after hemorrhagic shock (1, 12) , and a role has been assigned to the increased caspase-3 activity and reduction of ATP levels after hemorrhage (13) (14) (15) . Proteolytic fragments derived as a result of caspase-3-mediated cleavage are cleared up by the proteasome complex (6) .
In the present study, hemorrhage decreased ATP levels in jejunum, lung, heart, kidney, and brain tissue lysates. ATP levels in brain and kidney tissues returned to basal levels, whereas in the jejunum, lung, and heart, ATP levels remained below the basal levels. Although the hemorrhage-associated low levels of ATP in the jejunum, lung, and heart have been proposed to be responsible for the delayed hemorrhage manifestations such as MOD and MOF, the exact mechanism(s) is not known.
The decrease in ATP levels after hemorrhage was caused at least in part by decreases in the enzymatic activity and protein expression of PDH, an enzyme that catalyzes the oxidative decarboxylation of pyruvate to generate acetyl-CoA, thereby linking glycolysis to the tricarboxylic acid cycle with respect to substrate. These hemorrhage-induced decreases are not likely related to the increase in caspase-3 because iNOS gene-transfected cells exhibited the increased caspase-3 activity and protein level without altering the levels of PDH and ATP (J. G. Kiang, unpublished data). However, the possibility that other caspases are involved in PDH metabolism cannot be ruled out. Furthermore, whether enzymes other than PDH are altered by hemorrhage remains to be elucidated. In this study, we found that GA treatment prevented the hemorrhage-induced decrease in PDH enzymatic activity and its subsequent decrease in ATP levels. Kline et al. (18) reported that increased ATP after activation of PDH improves heart function and metabolism after hemorrhagic shock. Therefore, this GA-mediated inhibition of the PDH activity reduction and ATP loss can be relevant in preventing MOD and MOF after hemorrhage. This was further confirmed by the observation of GA inhibition on mucosal injury of the hemorrhaged jejunum (Fig. 4, B vs. D) .
The view is reinforced by the following facts: 1) GA induces HSP70i overexpression, which confers cytoprotection against hemorrhagic injury (13, 14, 17, 25) ; 2) GA inhibits KLF6 expression that is activated by hemorrhage (13, 14) or wound repair (27) ; 3) GA inhibits hemorrhage-induced iNOS overexpression, which diminishes iNOS-induced cell injury (9, (12) (13) (14) (15) 25) ; 4) GA treatment effectively decreases the hemorrhageinduced increase in apoptosis (14) ; and 5) GA increases ATP levels (Fig. 11) . Therefore, it is reasonable to surmise that GA has potential therapeutic effects and that it can be used to limit the acute and delayed injury resulted from hemorrhage.
We propose that the GA-induced inhibition of hemorrhageinduced ATP loss is in part mediated by its induction of HSP70i because 1) HSP70 forced overexpression enables the increases in PDH enzymatic activity, its protein expression, and ATP levels; 2) HSP70 siRNA treatment decreases PDH enzymatic activity, its protein expression, and ATP levels; and 3) HSP70 forms complex with PDH in both mouse jejunum tissues and GA-treated cultured cells, which may preserve the PDH activity and its integrity. On the other hand, GA directly upregulates PDH protein, which may also contribute to the reduction of the ATP loss and mucosal injury induced by hemorrhage.
The GA-induced increase in ATP is external Na ϩ dependent and influenced by external K ϩ . This observation is consistent with findings reported by Portelli (26) , which indicate that Ca 2ϩ and Na ϩ favor the breaking of the high-energy bond of the ATP molecule, whereas K ϩ and Mg 2ϩ help rebuild it. Therefore, the absence of extracellular Na ϩ and presence of additional extracellular K ϩ do not favor ATP generation. Increases in extracellular K ϩ may also increase the activity of Na ϩ -K ϩ -ATPase and thereby deplete intracellular ATP levels. Figure 12 presents a model for the interaction between hemorrhage-induced changes, depicting points where GA might block these changes. On the basis of our data and those from other laboratories (30) , hemorrhage decreases PDH enzymatic activity and its protein levels, which results in decreased intracellular ATP. Low ATP levels cause mitochondria disruption. Because apoptosis requires energy, if the levels of ATP remain at levels Ͼ15% of baseline, then apoptosis ensues. Fig. 12 . Schematic representation of the model for ATP after hemorrhage and the points where GA might block the changes. Hemorrhage decreases PDH activity, which leads to low ATP levels. Low ATP levels cause mitochondrial disruption, which results in either apoptosis or necrosis depending on the level of ATP left in the cell (4, 19 -21, 31) . GA increases HSP70i expression, which forms complexes with PDH and preserves both protein levels and activity. GA also increases PDH protein.
The GA-induced ATP increase is regulated by external Na ϩ and K ϩ .
If the ATP levels fall below 15% of baseline, then necrosis ensues (4, 19 -21, 31 ). Our observations show that GA treatment blocks the hemorrhage-induced decrease in PDH and increases PDH protein. The GA-induced HSP70i overexpression forms a complex with PDH, leading to cytoprotection. As a result, subsequent events are also blocked. The GA-induced ATP increase is regulated by external Na ϩ and K ϩ . In summary, we are the first to show that hemorrhage reduces PDH activity and its protein. GA treatment increases PDH activity and its protein as well as HSP70i protein. The increase in HSP70 forms a complex with PDH, together with an increased PDH protein level, to cytoprotect against undesirable outcomes such as ATP loss. Our results, taken together with findings from other laboratories (22, 25) , indicate that GA may be therapeutically useful before surgery or as an additive to resuscitation fluids to reduce hemorrhage-induced injury.
